Tannaz Ranjbarian, Michela Del Simone, Mark Antkowiak, Shirley Sarno, Shumei Kato, Adam Burgoyne, Elena Fumagalli, Dario Callegaro, Paul T. Fanta, Alessandro Gronchi, Jason K. Sicklick. "Oncologic equivalence of brand-name vs generic imatinib in neoadjuvant
                    <i>KIT</i>
                    exon 11 GIST: A real-world international cohort study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.11535